DK1191927T3 - Mikroreservoirsystem på basis af polysiloxaner og ambifile opløsningsmidler - Google Patents

Mikroreservoirsystem på basis af polysiloxaner og ambifile opløsningsmidler

Info

Publication number
DK1191927T3
DK1191927T3 DK00936897T DK00936897T DK1191927T3 DK 1191927 T3 DK1191927 T3 DK 1191927T3 DK 00936897 T DK00936897 T DK 00936897T DK 00936897 T DK00936897 T DK 00936897T DK 1191927 T3 DK1191927 T3 DK 1191927T3
Authority
DK
Denmark
Prior art keywords
ambifilic
polysiloxanes
solvents
system based
reservoir system
Prior art date
Application number
DK00936897T
Other languages
Danish (da)
English (en)
Inventor
Walter Mueller
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19958554A external-priority patent/DE19958554C2/de
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Application granted granted Critical
Publication of DK1191927T3 publication Critical patent/DK1191927T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Silicon Polymers (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
  • Transformer Cooling (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
DK00936897T 1999-07-02 2000-06-20 Mikroreservoirsystem på basis af polysiloxaner og ambifile opløsningsmidler DK1191927T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19930340 1999-07-02
DE19958554A DE19958554C2 (de) 1999-07-02 1999-12-04 Mikroreservoirsystem auf Basis von Polysiloxanen und ambiphilen Lösemitteln und ihre Herstellung
PCT/EP2000/005658 WO2001001967A1 (de) 1999-07-02 2000-06-20 Mikroreservoirsystem auf basis von polysiloxanen und ambiphilen lösemitteln

Publications (1)

Publication Number Publication Date
DK1191927T3 true DK1191927T3 (da) 2003-05-26

Family

ID=26054014

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00936897T DK1191927T3 (da) 1999-07-02 2000-06-20 Mikroreservoirsystem på basis af polysiloxaner og ambifile opløsningsmidler

Country Status (22)

Country Link
US (2) US10532033B2 (hu)
EP (1) EP1191927B1 (hu)
JP (1) JP4428899B2 (hu)
CN (1) CN1195505C (hu)
AT (1) ATE234081T1 (hu)
AU (1) AU774740B2 (hu)
BR (1) BR0012152A (hu)
CA (1) CA2374930C (hu)
CZ (1) CZ301726B6 (hu)
DK (1) DK1191927T3 (hu)
ES (1) ES2194736T3 (hu)
HK (1) HK1047234B (hu)
HU (1) HU229085B1 (hu)
IL (1) IL147247A0 (hu)
MX (1) MXPA02000118A (hu)
NZ (1) NZ515953A (hu)
PL (1) PL197492B1 (hu)
PT (1) PT1191927E (hu)
RU (1) RU2263502C2 (hu)
TR (1) TR200103845T2 (hu)
TW (2) TWI255723B (hu)
WO (1) WO2001001967A1 (hu)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2374930C (en) 1999-07-02 2008-08-05 Lts Lohmann Therapie-Systeme Ag Microreservoir system based on polysiloxanes and ambiphilic solvents
DE10141651B4 (de) 2001-08-24 2007-02-15 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System (TTS) mit dem Wirkstoff Fentanyl und Verfahren zu seiner Herstellung
US8246980B2 (en) * 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system
PL219512B1 (pl) 2003-04-14 2015-05-29 Lohmann Therapie Syst Lts Plaster miejscowy, zastosowanie plastra miejscowego i sposób wytwarzania plastra miejscowego
DE102004044578A1 (de) 2004-09-13 2006-03-30 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit einer Haftschicht, Verfahren zum Silikonisieren einer Rückschicht des Systems und Verwendung der Rückschicht
KR100764679B1 (ko) * 2005-07-22 2007-10-09 익수제약 주식회사 파록세틴을 함유하는 경피투여용 패취제
DE102006054732B4 (de) * 2006-11-21 2010-12-30 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit Ionenpaar-Mikroreservoiren
DE102006054731B4 (de) * 2006-11-21 2013-02-28 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreichung des Wirkstoffs Buprenorphin und Verwendung desselben in der Schmerztherapie
DE102007041557B4 (de) * 2007-08-29 2011-03-31 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System enthaltend längliche Hohlkörper
SG11201403162XA (en) 2011-12-12 2014-10-30 Lohmann Therapie Syst Lts Transdermal delivery system comprising buprenorphine
DE102011090178A1 (de) 2011-12-30 2013-07-04 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit geringer Neigung zur Spontankristallisation
TW201431570A (zh) 2012-11-22 2014-08-16 Ucb Pharma Gmbh 用於經皮投服羅替戈汀(Rotigotine)之多天式貼片
DK2810646T3 (en) * 2013-06-04 2016-10-31 Lts Lohmann Therapie Systeme Ag A transdermal
ES2694662T3 (es) 2013-07-03 2018-12-26 Lts Lohmann Therapie-Systeme Ag Sistema terapéutico transdérmico con componente electrónico
CA2948220C (en) 2014-05-20 2023-06-20 Lts Lohmann Therapie-Systeme Ag Transdermal delivery system containing rotigotine
EP4238580A3 (en) 2014-05-20 2023-10-25 LTS Lohmann Therapie-Systeme AG Transdermal delivery system including an interface mediator
EP2946776A1 (de) 2014-05-20 2015-11-25 LTS LOHMANN Therapie-Systeme AG Transdermales therapeutisches System zur Abgabe von Amitriptylin
CA2948219C (en) 2014-05-20 2023-04-04 Lts Lohmann Therapie-Systeme Ag Method for adjusting the release of active agent in a transdermal delivery system
CN111093638B (zh) * 2017-09-04 2024-03-26 罗曼治疗系统股份公司 包含乳化剂的透皮递送系统

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
GB1361289A (en) 1971-06-14 1974-07-24 Alza Corp Bandage for administering drugs
US3946106A (en) * 1974-10-24 1976-03-23 G. D. Searle & Co. Microsealed pharmaceutical delivery device
US4053580A (en) * 1975-01-01 1977-10-11 G. D. Searle & Co. Microsealed pharmaceutical delivery device
US4036228A (en) * 1975-09-11 1977-07-19 Alza Corporation Osmotic dispenser with gas generating means
DE3333240A1 (de) 1983-09-12 1985-03-28 Schering AG, 1000 Berlin und 4709 Bergkamen Mittel zur transdermalen applikation von arzneimittelwirkstoffen
US4573996A (en) * 1984-01-03 1986-03-04 Jonergin, Inc. Device for the administration of an active agent to the skin or mucosa
ATE77962T1 (de) 1985-02-25 1992-07-15 Univ Rutgers Dosierungssystem fuer transdermale absorption von arzneimittelwirkstoffen.
US4818540A (en) * 1985-02-25 1989-04-04 Rutgers, The State University Of New Jersey Transdermal fertility control system and process
US4883669A (en) * 1985-02-25 1989-11-28 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for estradiol and other estrogenic steroids and process for administration
US5145682A (en) * 1986-05-30 1992-09-08 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for postmenopausal syndrome treatment and process for administration
GB8704755D0 (en) * 1987-02-28 1987-04-01 Dow Corning Ltd Pharmaceutical delivery device
CH674618A5 (hu) * 1987-04-02 1990-06-29 Ciba Geigy Ag
US5446070A (en) * 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
DE3910578A1 (de) 1989-03-29 1990-10-04 Schering Ag Mittel zur transdermalen applikation enthaltend gestoden
JP3238389B2 (ja) * 1988-10-27 2001-12-10 シエーリング アクチエンゲゼルシヤフト ゲストデン含有の経皮適用のための薬剤
US5788983A (en) * 1989-04-03 1998-08-04 Rutgers, The State University Of New Jersey Transdermal controlled delivery of pharmaceuticals at variable dosage rates and processes
DE4336557C2 (de) * 1993-05-06 1997-07-17 Lohmann Therapie Syst Lts Estradiolhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
DE4332093C2 (de) * 1993-09-22 1995-07-13 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit dem Wirkstoff Acetylsalicylsäure und Verfahren zu seiner Herstellung
US5688523A (en) * 1995-03-31 1997-11-18 Minnesota Mining And Manufacturing Company Method of making a pressure sensitive skin adhesive sheet material
US5906830A (en) * 1995-09-08 1999-05-25 Cygnus, Inc. Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
FR2740038B1 (fr) * 1995-10-20 1998-01-02 Lafon Labor Composition pour l'administration transdermique
DE19814084B4 (de) 1998-03-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
US6381852B1 (en) 1998-08-17 2002-05-07 Dart Industries, Inc. Pastry cutter set with combined storage case and support
HUP9802963A1 (hu) 1998-12-18 2000-12-28 József Bereznai Szagelszívás közvetlen a WC-csészéből és az ezt biztosító szerkezet
CA2374930C (en) 1999-07-02 2008-08-05 Lts Lohmann Therapie-Systeme Ag Microreservoir system based on polysiloxanes and ambiphilic solvents

Also Published As

Publication number Publication date
EP1191927B1 (de) 2003-03-12
HU229085B1 (en) 2013-07-29
US10709669B2 (en) 2020-07-14
AU5222000A (en) 2001-01-22
MXPA02000118A (es) 2003-02-27
BR0012152A (pt) 2002-03-12
CZ20014514A3 (cs) 2002-03-13
PT1191927E (pt) 2003-07-31
CN1356895A (zh) 2002-07-03
RU2263502C2 (ru) 2005-11-10
EP1191927A1 (de) 2002-04-03
AU774740B2 (en) 2004-07-08
JP4428899B2 (ja) 2010-03-10
HK1047234A1 (en) 2003-02-14
TW200425916A (en) 2004-12-01
CA2374930A1 (en) 2001-01-11
JP2003503445A (ja) 2003-01-28
HUP0201763A2 (hu) 2002-12-28
ES2194736T3 (es) 2003-12-01
HK1047234B (zh) 2005-07-29
TWI256311B (en) 2006-06-11
WO2001001967A1 (de) 2001-01-11
PL197492B1 (pl) 2008-04-30
TWI255723B (en) 2006-06-01
IL147247A0 (en) 2002-08-14
CN1195505C (zh) 2005-04-06
TR200103845T2 (tr) 2002-05-21
US10532033B2 (en) 2020-01-14
NZ515953A (en) 2003-06-30
ATE234081T1 (de) 2003-03-15
CA2374930C (en) 2008-08-05
US20040202710A1 (en) 2004-10-14
HUP0201763A3 (en) 2004-05-28
US20200060985A1 (en) 2020-02-27
PL352361A1 (en) 2003-08-11
CZ301726B6 (cs) 2010-06-02

Similar Documents

Publication Publication Date Title
DK1191927T3 (da) Mikroreservoirsystem på basis af polysiloxaner og ambifile opløsningsmidler
DK1421968T3 (da) Indretning til fiksering af et kateter og et filter
DK1914244T3 (da) Fremgangsmåde til at modulere aktiviteten af funktionelle immunmolekyler.
DK0914178T3 (da) Anordning til forøgelse af transdermal afgivelse eller prøveudtagning af et middel
ATE342097T1 (de) Elektroaktive pore
DK1272207T3 (da) Anvendelse af et botulinustoksin til fremstilling af et lægemiddel til perifer indgivelse til behandling af smerte, der ikke står i forbindelse med muskelspasme eller hovedpine
DK1178783T3 (da) Indretning og anvendelse til forögelse af den transdermale permeation af lægemidler
NO20053663L (no) Transdermal granistetron
BR0312671A (pt) Dispositivo de microagulhas, método para utilizar um dispositivo de microagulhas, e, método para aplicar um dispositivo de microagulhas
NO20012170D0 (no) Selvstendig, transportabel blodbehandlingsinnretning
DE122006000008I1 (de) Mikroreservoirsystem auf basis von Polysiloxanen und Ambiphilen L¦semitteln
BRPI0508894A (pt) meios para administração transdérmica de nicotina e uso
ATE455541T1 (de) Transdermales therapeutisches system (tts) mit dem wirkstoff fentanyl
ITMI20021972A1 (it) Dispositivo per uso medico.
DK1117363T3 (da) Vibrationsmassageindretning til behandling af smerter
DK1200081T3 (da) Anvendelse af escitalopram til behandling af generaliseret angstlidelse
ATE235422T1 (de) Gelierungsstabiele polyhalogenphosphazenverbindungen
ID30063A (id) Aplikator kosmetik yang diflokasikan
ITVI970166A0 (it) Dispositivo di ammortizzazione per bastoni da sci da escursionismo, da passeggio e per stampelle e simili
CY1105463T1 (el) Ελεγχομενη χορηγηση αντικαταθλιπτικων
DE50001618D1 (de) Hydrostatische lagervorrichtung
PT98416A (pt) Processo para a preparacao de um sistema matricial de silicone elastomerico autoadesivo destinado a administracao prolongada de piribedilo por via transcutanea
FR2821560B1 (fr) Seringue, ou dispositif similaire
DE50002348D1 (de) Spritzeneinrichtung
NO20022013L (no) Innretninger for transdermal legemiddellevering